CDH2 and cancer: Silencing of N-cadherin generates a less invasive and motile phenotype in cancer cell lines along with the down regulation of fibronectin and vimentin and increased expression of the epithelial marker E-cadherin, losing the stem cell-like features of mesenchymal cells [81].